Cabot (CBT) closed at $72.17 on November 12, 2026, down 0.1% from the previous close, on volume of 372,871 shares (30-day average 383,460).
Data as of November 12, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 30, 2026 | Put Spread Tied to Stock | 20-Nov-2670 : 75 P +100,000 Stock | 2,000 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Cabot Earnings Call Shows Strength Amid Market Pressures
TipRanks (Tue, 10-Nov 7:27 PM ET)
Cabot Corporation Reports Fourth Quarter and Fiscal Year 2026 Results
Globe Newswire (Mon, 2-Nov 4:31 PM ET)
Cabot Corporation to Announce Fourth Quarter Fiscal 2026 Operating Results
Globe Newswire (Tue, 13-Oct 4:04 PM ET)
Globe Newswire (Thu, 17-Sep 8:30 AM ET)
Cabot Corporation Appoints Steve Delahunt as Interim Chief Financial Officer
Globe Newswire (Tue, 15-Sep 8:30 AM ET)
Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029
Globe Newswire (Wed, 12-Aug 5:35 PM ET)
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Cabot trades on the NYSE stock market under the symbol CBT.
As of November 12, 2026, CBT stock price declined to $72.17 with 372,871 million shares trading.
CBT has a beta of 0.57, meaning it tends to be less sensitive to market movements. CBT has a correlation of 0.05 to the broad based SPY ETF.
CBT has a market cap of $3.73 billion. This is considered a Mid Cap stock.
Last quarter Cabot reported $1 billion in Revenue and $1.61 earnings per share. This beat revenue expectation by $78 million and exceeded earnings estimates by $.07.
In the last 3 years, CBT traded as high as $117.46 and as low as $58.33.
The top ETF exchange traded funds that CBT belongs to (by Net Assets): AVUV, IJH, VTI, IWM, VB.
CBT has outperformed the market in the last year with a return of +20.5%, while the SPY ETF gained +12.0%. However, in the most recent history, CBT shares have underperformed the stock market with its stock returning -16.5% in the last 3 month period and -2.2% for the last 2 week period, while SPY has returned -1.5% and -2.0%, respectively.
CBT support price is $70.90 and resistance is $73.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBT shares will trade within this expected range on the day.
